Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 3.174% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CCCCNc1c([N+](=O)[O-])cc(C(=O)O)cc1[N+](=O)[O-]
b O=S(=O)(/C=C/c1ccccc1)N1CCN(c2cccc(Cl)c2)CC1
Answer: b. O=S(=O)(/C=C/c1ccccc1)N1CCN(c2cccc(Cl)c2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=S(=O)(/C=C/c1ccccc1)N1CCN(c2cccc(Cl)c2)CC1
O=S(=O)(/C=C/c1ccccc1)N1CCN(c2cccc(Cl)c2)CC1
1-(3-chlorophenyl)-4-[(E)-2-phenylethenyl]sulfonylpiperazine